Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have chromatin binding activity. Involved in glucose homeostasis; positive regulation of growth hormone receptor signaling pathway; and regulation of growth. Predicted to localize to chromocenter; midbody; and nucleoplasm. Is expressed in several structures, including brain; liver; small intestine; spinal cord; and spleen. Used to study autosomal dominant non-syndromic intellectual disability. Human ortholog(s) of this gene implicated in autism spectrum disorder and autosomal dominant non-syndromic intellectual disability 1. Orthologous to human MBD5 (methyl-CpG binding domain protein 5).